Kurt Karst is speaking at the RDD Europe 2015

FDA's Orange Book and ANDA's: Questioning the Policies and Precedents Surrounding RLD Patent Listings.

When

May 5, 2015

The meeting format will include:

• In-depth discussions of the developing issues surrounding aerosol drug delivery including new therapeutic opportunities and drug design technologies, progress in drug development alongside novel in vitro and in vivo testing methods, regulatory science… and much more.

• Scientific Poster Sessions covering all aspects of regulatory science, formulation development, new research methods and advanced drug delivery technologies.

• Technology Exhibition in which excipient, device and equipment designers plus component and service suppliers present their latest developments in a table top format.

• Workshop Sessions featuring practical and interactive demonstrations of innovative technologies, products and services.

• Networking Opportunities Events are structured to enable you to squeeze maximum value from RDD Europe 2015. Many participants use RDD to sharpen their ideas and meet new business partners.